Appointed
Stephen Ilott
Director
TBH ·
Brag House Holdings, Inc.
Stephen Ilott 58 Director
Executive movement radar
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 501–550 of 35115
Appointed
Yassine Bouhara
Director
VII ·
Viking Acquisition Corp. II
When the election of Dr. Ackermann and Messrs. Brettschneider, Bouhara and Waugh as directors of the Company became effective on July 6, 2026, each of them entered into an indemnity agreement with the Company.
Appointed
Dr. Josef Ackermann
Director
VII ·
Viking Acquisition Corp. II
When the election of Dr. Ackermann and Messrs. Brettschneider, Bouhara and Waugh as directors of the Company became effective on July 6, 2026, each of them entered into an indemnity agreement with the Company.
Appointed
Seth Waugh
Director
VII ·
Viking Acquisition Corp. II
When the election of Dr. Ackermann and Messrs. Brettschneider, Bouhara and Waugh as directors of the Company became effective on July 6, 2026, each of them entered into an indemnity agreement with the Company.
Appointed
Fred Brettschneider
Director
VII ·
Viking Acquisition Corp. II
When the election of Dr. Ackermann and Messrs. Brettschneider, Bouhara and Waugh as directors of the Company became effective on July 6, 2026, each of them entered into an indemnity agreement with the Company.
Appointed
Donn Casale
Class III director
SPRY ·
ARS Pharmaceuticals, Inc.
Mr. Casale was also concurrently appointed to the Board as a Class III director, to serve until the Company’s 2029 annual meeting of stockholders.
Appointed
Manuel Benito Miranda
Class II Director
MTZ ·
MASTEC INC
On June 30, 2026, the Board of Directors (the “Board”) of the Company appointed Mr. Manuel Benito Miranda as a Class II director to fill a vacancy in that Board Class following an increase in the size of the Board from eight (8) to nine (9) directors.
Appointed
Lori Goltermann
Director
LFST ·
LifeStance Health Group, Inc.
on July 2, 2026, the Board appointed Thurman Justice, Lori Goltermann and Safwan Shabab as a directors of the Company.
Appointed
Safwan Shabab
Director
LFST ·
LifeStance Health Group, Inc.
on July 2, 2026, the Board appointed Thurman Justice, Lori Goltermann and Safwan Shabab as a directors of the Company.
Appointed
Thurman Justice
Director
LFST ·
LifeStance Health Group, Inc.
on July 2, 2026, the Board appointed Thurman Justice, Lori Goltermann and Safwan Shabab as a directors of the Company.
Departed
Jeffrey Rhodes
Director
LFST ·
LifeStance Health Group, Inc.
On July 2, 2026, Jeffrey Rhodes notified the LifeStance Health Group, Inc. (the “Company”) board of directors (the “Board”) of his resignation from the Board and all of its committees, effective immediately.
Departed
Stephen Markscheid
Director
Four Leaf Acquisition Corp
Effective July 7, 2026, the following directors resigned from the Board of Directors (the “Board”) of Four Leaf Acquisition Corporation (the “Company”): ● Alvin Wang ● Stephen Markscheid ● Rahul Mewawalla
Departed
Alvin Wang
Director
Four Leaf Acquisition Corp
Effective July 7, 2026, the following directors resigned from the Board of Directors (the “Board”) of Four Leaf Acquisition Corporation (the “Company”): ● Alvin Wang ● Stephen Markscheid ● Rahul Mewawalla
Appointed
Nanuk Warman
Independent Director
Four Leaf Acquisition Corp
Effective as of July 7, 2026, each of Nanuk Warman, Jay Izso and Mark DiSabato was appointed as independent director to the Company’s Board of Directors.
Departed
Rahul Mewawalla
Director
Four Leaf Acquisition Corp
Effective July 7, 2026, the following directors resigned from the Board of Directors (the “Board”) of Four Leaf Acquisition Corporation (the “Company”): ● Alvin Wang ● Stephen Markscheid ● Rahul Mewawalla
Appointed
Mark DiSabato
Independent Director
Four Leaf Acquisition Corp
Effective as of July 7, 2026, each of Nanuk Warman, Jay Izso and Mark DiSabato was appointed as independent director to the Company’s Board of Directors.
Appointed
Jay Izso
Independent Director
Four Leaf Acquisition Corp
Effective as of July 7, 2026, each of Nanuk Warman, Jay Izso and Mark DiSabato was appointed as independent director to the Company’s Board of Directors.
Departed
Shawn Morris
member of the Board of Directors
PRVA ·
Privia Health Group, Inc.
On July 6, 2026, Shawn Morris resigned from his position as a member of the Board of Directors (the “Board”) of Privia Health Group, Inc. (the “Company”) and as a member of the Compliance Committee of the Board, effective immediately.
Departed
Andrew Levin
Director
VOR ·
Vor Biopharma Inc.
On July 6, 2026, Andrew Levin, M.D., Ph.D., a member of the Board of Directors (the “Board”) of Vor Biopharma Inc. (the “Company”), delivered his notice of resignation, effective immediately.
Appointed
David Zaccardelli
Director
VOR ·
Vor Biopharma Inc.
On July 7, 2026, the Board appointed David Zaccardelli, Pharm.D. to the vacancy created by Dr. Levin’s resignation, to serve on the Board as an independent Class II director until the Company’s 2029 annual meeting of stockholders and until his successor is duly elected and qualified or his earlier resignation or removal.
Appointed
Gregory R. Allen
Director
FMAO ·
FARMERS & MERCHANTS BANCORP INC
On June 30, 2026, the Board of Directors of Farmers & Merchants Bancorp, Inc. (the “Company”) determined to appoint Gregory R. Allen to fill an open vacancy on its Board of Directors.
Departed
Lori M. Toomey
Director
Kingfish Holding Corp
Lori M. Toomey, a member of the Board of Directors (the “Board”) of Kingfish Holding Corporation (the “Company”), has advised the Company on June 30, 2026, that she has determined not to stand for re-election at the Company’s 2027 annual meeting of shareholders.
Departed
Amanda Baldwin
Director
OLPX ·
OLAPLEX HOLDINGS, INC.
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
Departed
Martha Morfitt
Director
OLPX ·
OLAPLEX HOLDINGS, INC.
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
Appointed
John Duffy
Director
OLPX ·
OLAPLEX HOLDINGS, INC.
In connection with the Merger, effective as of the Effective Time, Amanda Baldwin, John Duffy, Melisa Gill, and Martijn de Regt were appointed as directors of the Company.
Departed
Pamela Edwards
Director
OLPX ·
OLAPLEX HOLDINGS, INC.
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
Departed
Emily White
Director
OLPX ·
OLAPLEX HOLDINGS, INC.
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
Departed
Deirdre Findlay
Director
OLPX ·
OLAPLEX HOLDINGS, INC.
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
Departed
John P. Bilbrey
Director
OLPX ·
OLAPLEX HOLDINGS, INC.
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
Appointed
Martijn de Regt
Director
OLPX ·
OLAPLEX HOLDINGS, INC.
In connection with the Merger, effective as of the Effective Time, Amanda Baldwin, John Duffy, Melisa Gill, and Martijn de Regt were appointed as directors of the Company.
Departed
Tricia Glynn
Director
OLPX ·
OLAPLEX HOLDINGS, INC.
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
Appointed
Melisa Gill
Director
OLPX ·
OLAPLEX HOLDINGS, INC.
In connection with the Merger, effective as of the Effective Time, Amanda Baldwin, John Duffy, Melisa Gill, and Martijn de Regt were appointed as directors of the Company.
Departed
Christine Dagousset
Director
OLPX ·
OLAPLEX HOLDINGS, INC.
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
Appointed
Amanda Baldwin
Director
OLPX ·
OLAPLEX HOLDINGS, INC.
In connection with the Merger, effective as of the Effective Time, Amanda Baldwin, John Duffy, Melisa Gill, and Martijn de Regt were appointed as directors of the Company.
Departed
Jerome Griffith
Director
OLPX ·
OLAPLEX HOLDINGS, INC.
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
Departed
Michael White
Director
OLPX ·
OLAPLEX HOLDINGS, INC.
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
Departed
David Mussafer
Director
OLPX ·
OLAPLEX HOLDINGS, INC.
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
Appointed
Jonathan M. Pfohl
Director
MGTI ·
MGT CAPITAL INVESTMENTS, INC.
Jonathan M. Pfohl, who currently serves as the Company’s Interim Chief Executive Officer and Chief Financial Officer, was appointed to serve as a member of the Board.
Appointed
David M. Garrity
Director
MGTI ·
MGT CAPITAL INVESTMENTS, INC.
David M. Garrity was appointed as an independent member of the Board to hold office until the next annual meeting of stockholders and until his successor is duly elected and qualified.
Departed
Aitan Zacharin
Director
GCAN ·
Greater Cannabis Company, Inc.
Upon expiration of such period, Mr. Zacharin’s resignation as a director will become effective and Mr. Sanchez Talavera will remain as the sole director of the Company.
Appointed
John M. Lutz
Director
PLUS ·
EPLUS INC
appointed John M. Lutz, 64, to the Board, filling the vacancy.
Appointed
Laurie Keating
Director
KLRS ·
Kalaris Therapeutics, Inc.
On July 3, 2026, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, the Board elected Laurie Keating to serve as a member of the Board, effective as of August 1, 2026.
Departed
Morana Jovan-Embiricos
Director
KLRS ·
Kalaris Therapeutics, Inc.
On July 3, 2026, Morana Jovan-Embiricos, Ph.D., notified Kalaris Therapeutics, Inc. (the “Company”) of her decision to resign as a member of the Company’s board of directors (the “Board”), effective immediately.
Appointed
Lynn Seely
Class III Director
ABCL ·
AbCellera Biologics Inc.
On June 30, 2026, the Board of Directors (the "Board") of AbCellera Biologics Inc. (the "Company") appointed Lynn Seely, M.D as a new Class III director.
Appointed
David Gaertner
Director
RADC ·
Readvantage Corp.
On July 2, 2026, the Board of Directors of the Readvantage Corp. (the “Company”) appointed David Gaertner and David Mutina to serve as members of the Company's Board of Directors (the “Board”).
Appointed
David Mutina
Director
RADC ·
Readvantage Corp.
On July 2, 2026, the Board of Directors of the Readvantage Corp. (the “Company”) appointed David Gaertner and David Mutina to serve as members of the Company's Board of Directors (the “Board”).
Appointed
Carl R. Christenson
Class A director
MOG-A ·
MOOG INC.
On July 6, 2026, Moog Inc. (the “Company”) announced the election of Mr. Carl R. Christenson as a Class A director of the Company, effective July 1, 2026, after increasing the size of the Board of Directors (the “Board”) from nine to ten directors.
Departed
Cathy T. McCarthy
Member of the Board of Directors
MIDD ·
MIDDLEBY Corp
each of Mr. Robert A. Nerbonne and Ms. Cathy T. McCarthy resigned from their positions as members of the Board of Directors of the Company, to serve on the Board of Directors of Midera.
Departed
Robert A. Nerbonne
Member of the Board of Directors
MIDD ·
MIDDLEBY Corp
each of Mr. Robert A. Nerbonne and Ms. Cathy T. McCarthy resigned from their positions as members of the Board of Directors of the Company, to serve on the Board of Directors of Midera.
Departed
André Branch
director
SIG ·
SIGNET JEWELERS LTD
On July 2, 2026, André Branch informed the Board of Directors (the “Board”) of Signet Jewelers Limited (the “Company”) of his decision to resign as a director of the Board, effective immediately.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.